Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine

Molecular Pharmacology

Volumn 57, Issue 1, 2000, Pages 75-81

  Fitzgerald, Lawrence W ^a   Burn, Timothy C ^a   Brown, Barry S ^a   Patterson, John P ^a   Corjay, Martha H ^a   Valentine, Patricia A ^a   Sun, Jung Hui ^a   Link, John R ^a   Abbaszade, Ilgar ^a   Hollis, Jeannine M ^a   Largent, Brian L ^a   Hartig, Paul R ^a   Hollis, Gregory F ^a   Meunier, Paul C ^a   Robichaud, Albert J ^a   Robertson, David W ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXFENFLURAMINE; ERGOTAMINE; FENFLURAMINE; METHYSERGIDE; NORFENFLURAMINE; SEROTONIN 2B RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SCREENING; HEART DISEASE; HEART VALVE; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SWINE;

ANIMALS; APPETITE DEPRESSANTS; CELL LINE; FENFLURAMINE; HEART VALVE DISEASES; HEART VALVES; HUMANS; MOLECULAR SEQUENCE DATA; NORFENFLURAMINE; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2B; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; RNA, MESSENGER; SEROTONIN AGENTS; SWINE;

EID: 0033989494     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Caccia S, Conforti I, Duchier J and Garattini G (1985) Pharmacokinetics of fenfluramine and norfenfluramine in volunteers given d- and d,l-fenfluramine for 15 days. Eur J Clin Pharmacol 29:221-224.
2. Choi DS, Kellermann O, Richard S, Colas JF, Bolanos-Jimenez F, Tournois C, Launay JM, Maroteaux L (1998) Mouse 5-HT2B receptor-mediated serotonin trophic functions. Ann NY Acad Sci 861:67-73.
3. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD and Schaff HV (1997) Valvular heart disease associated with fenfluramine-phentermine. (1997) N Engl J Med 337:581-588.
4. Curzon G, Gibson EL and Oluyomi AO (1997) Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. Trends Pharmacol Sci 18:21-25.
5. Davis LG, Dibner MD and Battey JF (1986) Basic Methods in Molecular Biology, Elsevier, New York.
6. 2C receptors: Evidence favoring the ternary complex and two-state models of agonist action. J Neurochem 72:2127-2134.
7. Gibson UE, Heid CA and Williams PM (1996) A novel method for real time quantitative RT-PCR. Genome Res 6:995-1001.
8. Huang Z, Fasco MJ and Kaminsky LS (1996) Optimization of DNase I removal of contaminating DNA from RNA for use in quantitative RNA-PCR. Biotechniques 20:1012-1020.
9. Kulke MH and Mayer RJ (1999) Carcinoid tumors. N Engl J Med 340:858-867.
10. 2B) from rat fundus. Mol Pharmacol 42:549-557.
11. Johnson KW, Phebus LA and Cohen ML (1998) Serotonin in migraine: Theories, animal models and emerging therapies. Prog Drug Res 51:219-244.
12. Julius D, Livelli TJ, Jessell TM and Axel R (1989) Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. Science (Wash DC) 244:1057-1062.
13. Launay J-M, Birraux G, Bondoux D, Callebert J, Choi D-S, Loric S and Maroteaux L (1996) Ras involvement in signal transduction by the serotonin 5-HT2B receptor. J Biol Chem 271:3141-3147.
14. Lopez-Ilasaca M (1998) Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades. Biochem Pharmacol 56: 269-277.
15. Muller-Schweinitzer E and Tapparelli C (1986) Methyergonovine, an active metabolite of methysergide. Cephalalgia 6:35-41.
16. Newton RA, Phipps SL, Flanigan TP, Newberry NR, Carey JE, Kumar C, McDonald B, Chen C and Elliott JM (1996) Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: Comparative stimulation by hallucino-genic drugs. J Neurochem 67:2521-2531.
17. Schmuck K, Ullmer C, Kalkman HO, Probst A and Lubbert H (1996) Activation of meningeal 5-HT2B receptors: An early step in the generation of migraine headache? Eur J Neurosci 8:959-967.
18. Spinelli R, Fracasso C, Guiso G, Garattini S and Caccia S (1988) Disposition of (-)-fenfluramine and its active metabolite (-)-norfenfluramine in rat: A single dose-proportionality study. Xenobiotica 18:573-584.
19. Ullmer C, Schmuck K, Kalkman HO and Lubbert H (1995) Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett 370:215-221.
20. Wee CC, Phillips RS, Aurigemma G, Erban S, Kriegel G, Riley M and Douglas PS (1998) Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication. Ann Intern Med 129:870-874.